Safety and Efficacy of Intravenous Trappsol Cyclo (HPBCD) in Niemann-Pick Type C Patients

Clinical trial NCT02912793 · COMPLETED

Trial details

NCT number: NCT02912793
Sponsor: Cyclo Therapeutics, Inc.
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Niemann-Pick Disease, Type C1

Start date: 2017-03-20
Primary completion: 2021-03-03
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.